diazomethane has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, H; Ding, W; Kuang, S; Kumar, M; Liang, SH; Mondal, P; Ran, C; Shen, S; Tanzi, RE; Wu, B; Yang, F; Yang, L; Zhang, C; Zhang, J; Zhu, B | 1 |
| Bataller, R; Odena, G; Orman, ES | 1 |
| Bahr, BA; Bowers, MT; Gessel, MM; Viswanathan, K; Wisniewski, ML; Wright, DL; Zheng, X | 1 |
| Bahr, BA; Bendiske, J | 1 |
1 review(s) available for diazomethane and Disease Models, Animal
| Article | Year |
|---|---|
Alcoholic liver disease: pathogenesis, management, and novel targets for therapy.
Topics: Animals; Chemokines, CXC; Diazomethane; Disease Models, Animal; Endocannabinoids; Fatty Acids; Humans; Inflammasomes; Interleukin-22; Interleukins; Intestines; Lipopolysaccharides; Liver Diseases, Alcoholic; Molecular Targeted Therapy; Osteopontin; Receptors, Tumor Necrosis Factor; STAT3 Transcription Factor; Translational Research, Biomedical | 2013 |
3 other study(ies) available for diazomethane and Disease Models, Animal
| Article | Year |
|---|---|
A Photolabile Curcumin-Diazirine Analogue Enables Phototherapy with Physically and Molecularly Produced Light for Alzheimer's Disease Treatment.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Curcumin; Diazomethane; Disease Models, Animal; Mice; Mice, Transgenic; Phototherapy | 2023 |
Z-Phe-Ala-diazomethylketone (PADK) disrupts and remodels early oligomer states of the Alzheimer disease Aβ42 protein.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Diazomethane; Dimerization; Disease Models, Animal; Drug Design; Humans; Mass Spectrometry; Mice; Microscopy, Electron; Peptide Fragments; Protein Folding; Protein Structure, Secondary; Solubility | 2012 |
Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis--an approach for slowing Alzheimer disease?
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cathepsins; Chloroquine; Culture Techniques; Cysteine Proteinase Inhibitors; Diazomethane; Disease Models, Animal; Enzyme Activation; Hippocampus; Hydrolases; Lysosomes; Rats; Rats, Sprague-Dawley; Synapses; tau Proteins | 2003 |